FR115M - Nouveau sulfonamide utilisable en thérapeutique. - Google Patents

Nouveau sulfonamide utilisable en thérapeutique.

Info

Publication number
FR115M
FR115M FR835238A FR835238A FR115M FR 115 M FR115 M FR 115M FR 835238 A FR835238 A FR 835238A FR 835238 A FR835238 A FR 835238A FR 115 M FR115 M FR 115M
Authority
FR
France
Prior art keywords
usable
therapy
new sulfonamide
sulfonamide
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR835238A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
BASF Schweiz AG
Original Assignee
Ciba Geigy AG
Ciba AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application granted granted Critical
Publication of FR115M publication Critical patent/FR115M/fr
Application filed by Ciba Geigy AG, Ciba AG filed Critical Ciba Geigy AG
Priority to FR835238A priority Critical patent/FR115M/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • C07D231/42—Benzene-sulfonamido pyrazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR835238A 1958-03-14 1960-08-08 Nouveau sulfonamide utilisable en thérapeutique. Active FR115M (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR835238A FR115M (fr) 1958-03-14 1960-08-08 Nouveau sulfonamide utilisable en thérapeutique.

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH5704858A CH366545A (de) 1958-03-14 1958-03-14 Verfahren zur Herstellung neuer N-Acyl-sulfonamide
FR787914 1959-02-27
FR835238A FR115M (fr) 1958-03-14 1960-08-08 Nouveau sulfonamide utilisable en thérapeutique.

Publications (1)

Publication Number Publication Date
FR115M true FR115M (fr) 1960-01-09

Family

ID=4520879

Family Applications (1)

Application Number Title Priority Date Filing Date
FR835238A Active FR115M (fr) 1958-03-14 1960-08-08 Nouveau sulfonamide utilisable en thérapeutique.

Country Status (4)

Country Link
CH (1) CH366545A (fr)
ES (1) ES247571A1 (fr)
FR (1) FR115M (fr)
SE (1) SE301476B (fr)

Also Published As

Publication number Publication date
SE301476B (fr) 1968-06-10
ES247571A1 (es) 1960-01-01
CH366545A (de) 1963-01-15

Similar Documents

Publication Publication Date Title
FR302M (fr) Nouvelle m-butoxy-phénoxy-éthylamine utilisable en thérapeutique.
FR308M (fr) Nouvelle pyridyl-éthyl-guanidine utilisable en thérapeutique.
FR115M (fr) Nouveau sulfonamide utilisable en thérapeutique.
FR164M (fr) Nouvelle hydrazine utilisable en thérapeutique.
FR116M (fr) Nouveau dérivé sulfonamidique utilisable en thérapeutique.
FR1898M (fr) Nouvelle substance utilisable en thérapeutique.
FR221M (fr) Nouvelle guanidine utilisable en thérapeutique.
FR163M (fr) Nouvelle phénoxy-éthylamine utilisable en thérapeutique.
FR353M (fr) Nouvelle quinoléine utilisable en thérapeutique.
FR349M (fr) Nouvelle 1,3-dihydroxy-2-nitro-tricos-4-yne utilisable en thérapeutique.
FR350M (fr) Nouvel antibiotique lankavamycine utilisable en thérapeutique.
FR310M (fr) Nouvelle aza-hexylene-imino-éthyl-guanidine utilisable en thérapeutique.
DK106453C (da) Endoradiosonde.
FR351M (fr) Nouvel antibiotique lankavacidine utilisable en thérapeutique.
FR352M (fr) Nouvel antibiotique ferrimycine utilisable en thérapeutique.
BE596272A (fr) Nouvelle substance utilisable en thérapeutique.
BE583856A (fr) Agent opacifiant utilisable en readiologie.
FR1327304A (fr) Nouveau révélateur électrolytique utilisable en photoconductographie
FR1029M (fr) Nouveau 17α-isobutyl-androstane-3β,17β-diol utilisable en thérapeutique.
FR117M (fr) Nouveau biguanide utilisable en thérapeutique.
ES63919Y (es) Hucha
FR1217838A (fr) Tirelire
FR3174M (fr) Nouvel δ-3β17β-dihydroxy-7α17α-diméthyl-19-nor-androstene utilisable en thérapie.
FR303M (fr) Nouvelle guanidine utilisable en thérapeutique.
FR348M (fr) Nouveau glucofuranoside 3,5,6-substitué utilisable en thérapeutique.